Jeffrey M. Dener
No más puestos en curso
Perfil
Jeffrey M.
Dener worked as a Senior Director of Process Chemistry at Virobay, Inc. in 2011.
Prior to that, he was a Director of Research & Development at Discovery Partners International LLC in 2002.
He also worked as a Senior Scientist at Shaman Pharmaceuticals, Inc. in 1994 and as a Research Scientist at Rhone-Poulenc Rorer, Inc. in 1993.
Additionally, he worked as a Scientist at Arris Pharmaceutical Corp.
in 1996 and as a Staff Scientist at Axys Advanced Technologies, Inc. from 1996 to 2001.
Dener received his undergraduate degree from Bucknell University and his doctorate from The Ohio State University.
Antiguos cargos conocidos de Jeffrey M. Dener.
| Empresas | Cargo | Fin |
|---|---|---|
| Discovery Partners International LLC | Director Técnico/Científico/I+D | 01/03/2002 |
Axys Advanced Technologies, Inc.
 Axys Advanced Technologies, Inc. Medical SpecialtiesHealth Technology Part of Infinity Pharmaceuticals, Inc., Axys Advanced Technologies, Inc. produces and markets novel compound diversity libraries for drug screening. Axys Advanced Technologies was acquired by Discovery Partners International, Inc. from Axys Pharmaceuticals, Inc. on April 28, 2000 for $60 million. | Corporate Officer/Principal | 01/03/2001 |
| Arris Pharmaceutical Corp. | Corporate Officer/Principal | 01/03/1996 |
Shaman Pharmaceuticals, Inc.
 Shaman Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shaman Pharmaceuticals, Inc. engages in the discovery, development, and marketing of novel, proprietary botanical dietary supplements from tropical plant sources. The company was founded by Lisa A. Conte in May 1989 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/03/1994 |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Corporate Officer/Principal | 01/06/1993 |
Formación de Jeffrey M. Dener.
| Bucknell University | Undergraduate Degree |
| The Ohio State University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Shaman Pharmaceuticals, Inc.
Shaman Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shaman Pharmaceuticals, Inc. engages in the discovery, development, and marketing of novel, proprietary botanical dietary supplements from tropical plant sources. The company was founded by Lisa A. Conte in May 1989 and is headquartered in San Francisco, CA. | Health Technology |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
| Arris Pharmaceutical Corp. | Commercial Services |
Axys Advanced Technologies, Inc.
Axys Advanced Technologies, Inc. Medical SpecialtiesHealth Technology Part of Infinity Pharmaceuticals, Inc., Axys Advanced Technologies, Inc. produces and markets novel compound diversity libraries for drug screening. Axys Advanced Technologies was acquired by Discovery Partners International, Inc. from Axys Pharmaceuticals, Inc. on April 28, 2000 for $60 million. | Health Technology |
| Discovery Partners International LLC |
- Bolsa de valores
- Insiders
- Jeffrey M. Dener
